Summary
54 / 100 · Bulios Score
What speaks for it
- Analysts expect revenue to grow by 40% this fiscal year.
- Earnings per share grew by 11% a year over the last 3 years.
What to watch
- The share price is above the Bulios Fair Price.
- It missed profit estimates 7 times in the last 8 quarters.
- Revenue grew by only 0.1% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensivePrice against the Bulios Fair Price
P/E against the industry (Banks)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 12.6 BRL for 1 BRL of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (BRL)
Diluted EPS (BRL)
- Analyst estimate
Revenue grew by 8.0% a year over 5 years. Over the last 3 years it grew by 0.1% a year. For the next fiscal year analysts expect revenue to grow by 40%. Earnings per share grew by 11% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 BRL of revenue goes
- Cost of sales 64 BRL
- Sales and administration 22 BRL
- Taxes and other 1.7 BRL
- Net profit 12 BRL
Net profit, industry median (Banks) 15 BRL
Out of every 100 BRL of revenue, 12 BRL is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 1.65%
- Paid out of profit
- 21%
- Raised in a row
- 4 years
You receive R$ 0.89 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Neutral- Buy 4
- Hold 6
- Sell 1
No analyst has published a price target.
36% of the analysts recommend buying.
Analysts in detail